The Coalition against Typhoid (CaT), based at the Sabin Vaccine Institute (Sabin), works to prevent typhoid and other invasive salmonelloses through research, education, and advocacy. With more than 800 members, the Coalition acts as a catalyst in the global health community to coordinate partnerships, convene decision-makers, and advocate for sustainable solutions, including access to next-generation vaccines and clean water. The Coalition, formed in 2010, is guided by a multistakeholder steering committee. It is supported by the Bill & Melinda Gates Foundation.
Sabin, as the Secretariat of CaT, is implementing a large, landmark surveillance study to establish the burden of typhoid and paratyphoid in Bangladesh, India, Nepal, and Pakistan. Sabin is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policymakers, and public stakeholders to advance its vision of a future free from preventable diseases. As a nonprofit with more than two decades of experience, Sabin is committed to finding solutions that last and extending the full benefits of vaccines to all people, regardless of who they are or where they live. At Sabin, we believe in the power of vaccines to change the world. For more information, visit www.sabin.org and follow us on Twitter, @SabinVaccine.
Denise Garrett, MD, MSc
Dr. Denise Garrett, Vice President of Applied Epidemiology Programs, joined Sabin in August 2015 to lead Sabin’s work on typhoid and applied epidemiology. She serves as Director of the CaT Secretariat and leads a large surveillance project to help determine the burden of typhoid in Asia. Dr. Garrett received her medical training in Brazil with a special focus on infectious diseases, including typhoid fever.
Prior to joining Sabin, Dr. Garrett worked at the Centers for Disease Control and Prevention (CDC) for 23 years where she focused on international health and epidemiological research. During her tenure with CDC, Dr. Garrett led several multi-center infectious disease studies in both low-/lower middle-income and high-income countries. Dr. Garrett brings extensive experience collaborating with international governments, multilateral agencies, universities, and private-sector, nongovernmental, and global health organizations to expand infectious disease control and prevention and outbreak response programs around the world.
Noah Duff, Senior Associate of Applied Epidemiology Programs, joined Sabin in November 2018 to lead Sabin’s advocacy, policy and communications work on typhoid. She serves as the Manager of the CaT Secretariat, designing and implementing the Coalition’s activities. Prior to joining Sabin, Noah supported PATH’s Enteric Vaccine Initiative, a 10-year program that focused on advancing the development of safe and effective vaccines against the leading bacterial causes of diarrheal disease: Shigella and enterotoxigenic Escherichia coli.